We use cookies for a better user experience. Read our Privacy Policy

I Agree

Photodynamic Therapy Market

Photodynamic Therapy Market (Product Type: Photosensitizer Drugs and Devices; and Application: Cancer, Actinic Keratosis, Psoriasis, Acne, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Photodynamic Therapy Market Outlook 2031

  • The global photodynamic therapy market was valued at US$ 4.2 Bn in 2021
  • The global market is projected to advance at a CAGR of 13.5% from 2022 to 2031
  • The global photodynamic therapy market is anticipated to reach more than US$ 15.1 Bn by the end of 2031

Analysts’ Viewpoint on Photodynamic Therapy Market Scenario

Photodynamic therapy (PDT) is a part of treatment that uses drugs and devices for the treatment of chronic diseases such as cancer and malignant musculoskeletal tumors. Novel light-emitting devices are gaining traction for actinic keratosis treatment. Companies in the photodynamic treatment industry are consolidating their position through inorganic strategies such as label extensions. However, PDT faces common issues in drug-resistant breast cancer treatment, such as blood artery blockage, collapse, and final vascular shutdown. Therefore, companies should intensify their efforts to assess the benefits of photochemical internalization in facilitating the cytosolic transport of macromolecular medications to fight multidrug-resistant breast cancer.

photodynamic therapy market

Photodynamic Therapy Market Introduction

The global photodynamic therapy market is expected to be driven by the increase in incidence of skin diseases & cancer, rise in demand for minimally invasive procedures, and growth in the economic burden of cancer. Approval of novel biologics by regulatory agencies in developed and developing countries has provided patients with additional therapy alternatives. Companies offering photodynamic therapy are working on techniques to increase transdermal ALA delivery. They are creating micro-hole grating with high-power CO2 lasers. The usage of a soluble microneedle patch is another method that allows for continual ALA administration until the material gets entirely dissolved inside the lesion. Rise in awareness about photodynamic therapy benefits; and increase in adoption of face photodynamic therapy, eye photodynamic therapy, and acne photodynamic therapy are driving the global market. Rise in R&D activities in photodynamic therapy analysis is creating lucrative opportunities for market players.

Request a sample to get extensive insights into the Photodynamic Therapy Market

Rise in Prevalence of Skin Diseases to Drive Global Photodynamic Therapy Market

Skin infections are quite frequent, ranking fourth among the most common ailments globally. These are one of the leading causes of non-fatal disability, particularly in developing countries. Hence, there is a need to create a treatment regimen in order to reduce the economic burden of skin disorders in low-resource settings. Acne is one of the most prevalent skin disorders in the U.S., affecting around 50 million individuals each year. Its prevalence is higher in women, affecting more than 15% of the entire adult female population. The prevalence of herpes is higher in poor countries than in wealthy countries. Rise in genital herpes cases is part of a rapidly shifting picture of sexually transmitted disease epidemiology in emerging economies. Increase in prevalence of skin disorders and surge in economic burden of these illnesses have created a need for cost-effective treatment options. This is likely to augment the global photodynamic treatment market.

Chemical & Physical Stability and Photo Cytotoxicity of Photosensitizer Drugs Augmenting Market

In terms of product type, the global photodynamic therapy market has been bifurcated into photosensitizer drugs and devices. The photosensitizer drugs segment has been classified into porphyrin derivative (PD), aminolevulinic acid (ALA), and chlorines. The devices segment has been split into disposable fiber optic light delivery devices (DFOLDD) and diode lasers. The photosensitizer drugs segment held major share of the global market in 2021. The segment is projected to grow at a high CAGR during the forecast period owing to benefits such as high speed, low cost, and synthetic construction. Moreover, the chemical & physical stability of photosensitizer drugs and their photo cytotoxicity are anticipated to propel the segment.

Request a custom report on Photodynamic Therapy Market

Increase in Incidence of Cancer Augmenting PDT Treatment

Based on application, the global photodynamic therapy market has been categorized into cancer, actinic keratosis (AK), psoriasis, acne, and others. The cancer segment has been split into basal cell carcinoma, non-small cell lung cancer, head & neck cancer, and others. Cancer is the biggest cause of mortality globally. Tobacco use, pollution, changing lifestyles, and transfer of carcinogens and carcinogenic illnesses such as HPV, H. Pylori, and HCV contribute to the increase in cancer prevalence throughout the world. For instance, according to the National Cancer Institute, about 1,735,350 new cancer cases were likely to be diagnosed in the U.S. in 2018. The global photodynamic therapy market is expected to be driven by the rise in demand for photosensitizer medication and equipment used in the treatment of various forms of cancer.

Surge in demand for PDT due to increase in incidence of various malignancies, rise in number of surgeries, and accessibility of photosensitizer medications & devices are expected to augment the cancer segment during the forecast period. Increase in incidence of various forms of cancer, such as head and neck cancer; and rise in demand for treatment for breast cancer, lung cancer, and basal cell carcinoma treatment are propelling the cancer segment. Leading companies operating in the global photodynamic therapy market have secured drug patents for newly discovered compounds with potential use in photodynamic therapy for cancer treatment. Companies have also increased their focus on developing breast cancer drugs that can be used in photodynamic therapy.

Surge in Number of Hospitals Offering PDT to Cancer Patients Bolstering Hospitals Segment

In terms of end-user, the global photodynamic therapy market has been divided into hospitals, cosmetics & dermatology clinics, cancer treatment centers, and others. The hospitals segment is driven by the rise in demand for minimally invasive treatments, increase in awareness about the antitumor effects of PDT, and surge in number of hospitals offering PDT to cancer patients. Hospitals take special precautions to reduce or eliminate exposure to light or laser in order to protect healthy cells. Health care experts offer advice about what to do after treatment and what to avoid so that the therapy is more effective. Useful guidelines related to photodynamic therapy are given to patients in hospitals before and after extraction. This is expected to propel the hospitals segment during the forecast period.

Regional Outlook of Global Photodynamic Therapy Market

North America is projected to account for the leading share of the global photodynamic therapy market during the forecast period, owing to the presence of key players in the U.S., increase in demand for new biologics for cancer treatment, high rate of adoption of photodynamic therapy, and new product launches by market players. Increase in product approvals by the FDA, surge in usage of photodynamic therapy for the treatment & care of actinic keratosis, and rise in number of cosmetologists providing photodynamic therapy are boosting the photodynamic therapy market in North America.

Europe was the second-largest region of the global photodynamic therapy market in 2021. The market in the region is driven by the increase in research & development activities, rise in number of products receiving CE mark approval, and growth in usage of PDT in cancer treatment. The market in Asia Pacific is driven by the increase in incidence of cancer, psoriasis, and acne; patent awards by regulatory bodies in countries such as China; and geographic expansion by key companies.

Analysis of Key Players in Global Photodynamic Therapy Market

The global photodynamic therapy market is consolidated, with the presence of a small number of large-scale players. Key players operating in the global photodynamic therapy market include Galderma Laboratories, L.P., Biofrontera AG, Excel Lasers Limited, LUMIBIRD Group (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Technology Co., Ltd. These players are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers.

Key Developments in Global Photodynamic Therapy Market

  • In April 2021, Lumeda, Inc., a medical technology company that is developing photodynamic therapy (PDT) as intraoperative adjuvant therapy for patients undergoing lung cancer surgery, announced the completion of its Series A funding
  • In May 2020, Theralase Technologies, Inc., a company specializing in research and development of light-activated photodynamic compounds (PDC) and their associated drug formulations to safely and effectively destroy various cancers, received FDA Investigational New Drug (IND) approval to conduct a phase II non-muscle invasive bladder cancer (NMIBC) clinical study (study II) in the U.S.

Each of these players has been profiled in the photodynamic therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Photodynamic Therapy Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 4.2 Bn

Market Forecast Value in 2031

More than US$ 15.1 Bn

Growth Rate (CAGR) 2022-2031

13.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Photosensitizer Drugs
    • Porphyrin Derivative (PD)
    • Aminolevulinic Acid (ALA)
    • Chlorines
    • Others
    • Devices
    • Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • Diode Laser
  • Application
    • Cancer
      • Basal Cell Carcinoma
      • Non-Small Cell Lung Cancer
      • Head & Neck Cancer
      • Others
    • Actinic Keratosis (AK)
    • Psoriasis
    • Acne
    • Others
  • End-user
    • Hospitals
    • C&DC
    • CCC
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Galderma Laboratories, L.P.
  • Biofrontera AG
  • Excel Lasers Limited
  • LUMIBIRD group (Quantel Medical)
  • Modulight Corporation
  • Quest PharmaTech, Inc.
  • Theralase Technologies Inc.
  • SUS Advancing Technology Co., Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Photodynamic Therapy Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global photodynamic therapy market in 2021?

The global photodynamic therapy market was valued at US$ 4.2 Bn in 2021.

How big will be the global photodynamic therapy market in 2031?

The global photodynamic therapy market is projected to reach a value of more than US$ 15.1 Bn by 2031.

What was the CAGR of the global photodynamic therapy market from 2017 to 2021?

The global photodynamic therapy market grew at a CAGR of 13% from 2017 to 2021.

What will be the CAGR of the global photodynamic therapy market during the forecast period (2022–2031)?

The global photodynamic therapy market is anticipated to grow at a CAGR of 13.5% from 2022 to 2031.

What was the market share of the leading segment of the global photodynamic therapy market?

The photosensitizer drugs segment accounted for around 60% share of the global photodynamic therapy market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global photodynamic therapy market during the forecast period.

Who are the prominent players in the global photodynamic therapy market?

Galderma Laboratories, L.P., Biofrontera AG, Excel Lasers Limited, LUMIBIRD group (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies, Inc., and SUS Advancing Technology Co., Ltd.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Photodynamic Therapy Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. Covid-19 Impact Analysis

6. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Photosensitizer Drugs

            6.3.1.1. Porphyrin Derivative (PD)

                6.3.1.1.1. Hematoporphyrin Derivative (HpD)

                6.3.1.1.2. Benzoporphyrin Derivative (BPD)

                6.3.1.1.3. Texaphyrins

                6.3.1.1.4. Others

            6.3.1.2. Aminolevulinic acid (ALA)

            6.3.1.3. Chlorines

            6.3.1.4. Others

        6.3.2. Devices

            6.3.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            6.3.2.2. Diode Laser

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Photodynamic Therapy Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Cancer

            7.3.1.1. Basal Cell Carcinoma

            7.3.1.2. Non-Small Cell Lung Cancer

            7.3.1.3. Head & Neck Cancer

            7.3.1.4. Others

        7.3.2. Actinic Keratosis (AK)

        7.3.3. Psoriasis

        7.3.4. Acne

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Photodynamic Therapy Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. C&DC

        8.3.3. CCC

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Photodynamic Therapy Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Photodynamic Therapy Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2031

        10.2.1. Photosensitizer Drugs

            10.2.1.1. Porphyrin Derivative (PD)

                10.2.1.1.1. Hematoporphyrin Derivative (HpD)

                10.2.1.1.2. Benzoporphyrin Derivative (BPD)

                10.2.1.1.3. Texaphyrins

                10.2.1.1.4. Others

            10.2.1.2. Aminolevulinic acid (ALA)

            10.2.1.3. Chlorines

            10.2.1.4. Others

        10.2.2. Devices

            10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            10.2.2.2. Diode Laser

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Cancer

            10.3.1.1. Basal Cell Carcinoma

            10.3.1.2. Non-Small Cell Lung Cancer

            10.3.1.3. Head & Neck Cancer

            10.3.1.4. Others

        10.3.2. Actinic Keratosis (AK)

        10.3.3. Psoriasis

        10.3.4. Acne

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. C&DC

        10.4.3. CCC

        10.4.4. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Photodynamic Therapy Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2031

        11.2.1. Photosensitizer Drugs

            11.2.1.1. Porphyrin Derivative (PD)

                11.2.1.1.1. Hematoporphyrin Derivative (HpD)

                11.2.1.1.2. Benzoporphyrin Derivative (BPD)

                11.2.1.1.3. Texaphyrins

                11.2.1.1.4. Others

            11.2.1.2. Aminolevulinic acid (ALA)

            11.2.1.3. Chlorines

            11.2.1.4. Others

        11.2.2. Devices

            11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            11.2.2.2. Diode Laser

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Cancer

            11.3.1.1. Basal Cell Carcinoma

            11.3.1.2. Non-Small Cell Lung Cancer

            11.3.1.3. Head & Neck Cancer

            11.3.1.4. Others

        11.3.2. Actinic Keratosis (AK)

        11.3.3. Psoriasis

        11.3.4. Acne

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. C&DC

        11.4.3. CCC

        11.4.4. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2031

        12.2.1. Photosensitizer Drugs

            12.2.1.1. Porphyrin Derivative (PD)

                12.2.1.1.1. Hematoporphyrin Derivative (HpD)

                12.2.1.1.2. Benzoporphyrin Derivative (BPD)

                12.2.1.1.3. Texaphyrins

                12.2.1.1.4. Others

            12.2.1.2. Aminolevulinic acid (ALA)

            12.2.1.3. Chlorines

            12.2.1.4. Others

        12.2.2. Devices

            12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            12.2.2.2. Diode Laser

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Cancer

            12.3.1.1. Basal Cell Carcinoma

            12.3.1.2. Non-Small Cell Lung Cancer

            12.3.1.3. Head & Neck Cancer

            12.3.1.4. Others

        12.3.2. Actinic Keratosis (AK)

        12.3.3. Psoriasis

        12.3.4. Acne

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. C&DC

        12.4.3. CCC

        12.4.4. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. India

        12.5.3. Japan

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2031

        13.2.1. Photosensitizer Drugs

            13.2.1.1. Porphyrin Derivative (PD)

                13.2.1.1.1. Hematoporphyrin Derivative (HpD)

                13.2.1.1.2. Benzoporphyrin Derivative (BPD)

                13.2.1.1.3. Texaphyrins

                13.2.1.1.4. Others

            13.2.1.2. Aminolevulinic acid (ALA)

            13.2.1.3. Chlorines

            13.2.1.4. Others

        13.2.2. Devices

            13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            13.2.2.2. Diode Laser

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Cancer

            13.3.1.1. Basal Cell Carcinoma

            13.3.1.2. Non-Small Cell Lung Cancer

            13.3.1.3. Head & Neck Cancer

            13.3.1.4. Others

        13.3.2. Actinic Keratosis (AK)

        13.3.3. Psoriasis

        13.3.4. Acne

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. C&DC

        13.4.3. CCC

        13.4.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2031

        14.2.1. Photosensitizer Drugs

            14.2.1.1. Porphyrin Derivative (PD)

                14.2.1.1.1. Hematoporphyrin Derivative (HpD)

                14.2.1.1.2. Benzoporphyrin Derivative (BPD)

                14.2.1.1.3. Texaphyrins

                14.2.1.1.4. Others

            14.2.1.2. Aminolevulinic acid (ALA)

            14.2.1.3. Chlorines

            14.2.1.4. Others

        14.2.2. Devices

            14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            14.2.2.2. Diode Laser

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Cancer

            14.3.1.1. Basal Cell Carcinoma

            14.3.1.2. Non-Small Cell Lung Cancer

            14.3.1.3. Head & Neck Cancer

            14.3.1.4. Others

        14.3.2. Actinic Keratosis (AK)

        14.3.3. Psoriasis

        14.3.4. Acne

        14.3.5. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. C&DC

        14.4.3. CCC

        14.4.4. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2021

    15.3. Company Profiles

        15.3.1. Galderma Laboratories, L.P.

            15.3.1.1. Company Overview

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Business Strategies

            15.3.1.5. Recent Developments

        15.3.2. Biofrontera AG

            15.3.2.1. Company Overview

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Business Strategies

            15.3.2.5. 15.3.1.5. Recent Developments

        15.3.3. Excel Lasers Limited

            15.3.3.1. Company Overview

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Business Strategies

            15.3.3.5. Recent Developments

        15.3.4. LUMIBIRD group (Quantel Medical)

            15.3.4.1. Company Overview

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Business Strategies

            15.3.4.5. Recent Developments

        15.3.5. Modulight Corporation

            15.3.5.1. Company Overview

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Business Strategies

            15.3.5.5. Recent Developments

        15.3.6. Quest PharmaTech, Inc.

            15.3.6.1. Company Overview

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Business Strategies

            15.3.6.5. Recent Developments

        15.3.7. Theralase Technologies, Inc.

            15.3.7.1. Company Overview

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Business Strategies

            15.3.7.5. Recent Developments

        15.3.8. SUS Advancing Technology Co., Ltd.

            15.3.8.1. Company Overview

            15.3.8.2. Financial Overview

            15.3.8.3. Product Portfolio

            15.3.8.4. Business Strategies

            15.3.8.5. Recent Developments

List of Tables

Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031

Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031

Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031

Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region , 2017–2031

Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type,2017–2031

Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031

Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031

Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices,2017–2031

Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drug, 2017–2031

Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031

Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031

Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031

Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031

Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031

Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031

Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031

Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031

Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031

Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031

Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031

Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031

Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2021

Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2021

Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2021

Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2021

Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2017 and 2031

Figure 07: Global Photodynamic Therapy Market Value Share (%), by Photosensitizer Drugs, 2017 and 2031

Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photosensitizer Drugs, 2017–2031

Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017–2031

Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017–2031

Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017–2031

Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017–2031

Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017–2031

Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017–2031

Figure 16: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 17: Global Photodynamic Therapy Market Attractiveness Analysis, by Photosensitizer Drugs, 2021–2031

Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Devices, 2021–2031

Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2017 and 2031

Figure 20: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2021–2031

Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017–2031

Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017–2031

Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017–2031

Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017–2031

Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2017 and 2031

Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2031

Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017–2031

Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017–2031

Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2017 and 2031

Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2021-2031

Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country, 2017 and 2031

Figure 36: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2022–2031

Figure 37: North America Photodynamic Therapy Market Value Share, by Product Type, 2017and 2031

Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031

Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031

Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017and 2031

Figure 45: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

Figure 46: Europe Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031

Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2017 and 2031

Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031

Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031

Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2017 and 2031

Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031

Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 63: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031

Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2017–2031

Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031

Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2017–2031

Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031

Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031

Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2017 and 2031

Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031

Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

241

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved